| Literature DB >> 9891689 |
R D Maw1.
Abstract
The treatment of anogenital warts has long been unsatisfactory, with high treatment failure rates and relapse rates. It would seem that a good cell-mediated immune response is important for successful treatment, and the development of immune response modifiers such as Imiquimod give hope for an improved outcome for many patients.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9891689 DOI： 10.1016/s0733-8635(05)70055-3
Source DB: PubMed Journal: Dermatol Clin ISSN： 0733-8635 Impact factor: 3.478